価格表

在庫・価格 : 2025年04月30日 07時48分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-BRD4, Rabbit-Poly
データシート
A301-985A50 BETベチル ラボラトリーズ
Bethyl Laboratories, Inc.
0.05 ml ¥109,000
(未発注)
追加

在庫・価格 : 2025年04月30日 07時48分 現在

Anti-BRD4, Rabbit-Poly

  • 商品コード:A301-985A50
  • メーカー:BET
  • 包装:0.05ml
  • 価格: ¥109,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Powell ML et al. NCoR1 mediates papillomavirus E8;E2C transcriptional repression. J. Virol. 2010 May;84(9):4451-60
Powell ML et al
2010/01/01
Application: WB PubMed
2 Rahman S et al. The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3. Mol. Cell. Biol. 2011 Jul;31(13):2641-52
Rahman S et al
2011/01/01
Application: ChIP PubMed
3 Mertz JA et al. Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc. Natl. Acad. Sci. U.S.A. 2011 Oct;108(40):16669-74
Mertz JA et al
2011/01/01
Application: ChIP PubMed
4 Zhu J et al. Reactivation of latent HIV-1 by inhibition of BRD4. Cell Rep 2012 Oct;2(4):807-16
Zhu J et al
2012/01/01
Application: WB PubMed
5 Zou Z et al. Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA. Oncogene 2013 May;
Zou Z et al
2013/01/01
PubMed
6 Domsic JF et al. Molecular basis for oligomeric-DNA binding and episome maintenance by KSHV LANA. PLoS Pathog. 2013;9(10):e1003672
Domsic JF et al
2013/01/01
PubMed
7 Wu X et al. Bromodomain and extraterminal (BET) protein inhibition suppresses human T cell leukemia virus 1 (HTLV-1) Tax protein-mediated tumorigenesis by inhibiting nuclear factor κB (NF-κB) signaling. J. Biol. Chem. 2013 Dec;288(50):36094-10
Wu X et al
2013/01/01
PubMed
8 Anders L et al. Genome-wide localization of small molecules. Nat. Biotechnol. 2014 Jan;32(1):92-6
Anders L et al
2014/01/01
PubMed
9 Patel AJ et al. BET bromodomain inhibition triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors through Bim induction. Cell Rep 2014 Jan;6(1):81-92
Patel AJ et al
2014/01/01
PubMed
10 McLure KG et al. RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist. PLoS ONE 2013;8(12):e83190
McLure KG et al
2013/01/01
PubMed
11 Meng S et al. BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction. J. Dent. Res. 2014 May;93(7):657-662
Meng S et al
2014/01/01
PubMed
12 Sahai V et al. BET Bromodomain Inhibitors Block Growth of Pancreatic Cancer Cells in Three-Dimensional Collagen. Mol. Cancer Ther. 2014 May;
Sahai V et al
2014/01/01
PubMed
13 Michaeloudes C et al. Bromodomain and extraterminal proteins suppress NF-E2-related factor 2-mediated antioxidant gene expression. J. Immunol. 2014 May;192(10):4913-20
Michaeloudes C et al
2014/01/01
PubMed
14 Feng Q et al. An epigenomic approach to therapy for tamoxifen-resistant breast cancer. Cell Res. 2014 Jul;24(7):809-19
Feng Q et al
2014/01/01
PubMed
15 French CA et al. NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism. Cancer Discov 2014 Aug;4(8):928-41
French CA et al
2014/01/01
PubMed
16 Long J et al. The BET Bromodomain Inhibitor I-BET151 Acts Downstream of Smoothened Protein to Abrogate the Growth of Hedgehog Protein-driven Cancers. J. Biol. Chem. 2014 Dec;289(51):35494-502
Long J et al
2014/01/01
PubMed
17 Horne GA et al. Nanog requires BRD4 to maintain murine embryonic stem cell pluripotency and is suppressed by bromodomain inhibitor JQ1 together with Lefty1. Stem Cells Dev. 2015 Apr;24(7):879-91
Horne GA et al
2015/01/01
PubMed
18 Park-Min KH et al. Inhibition of osteoclastogenesis and inflammatory bone resorption by targeting BET proteins and epigenetic regulation. Nat Commun 2014;5:5418
Park-Min KH et al
2014/01/01
PubMed
  • No.: 1
  • 文献情報:
    Powell ML et al. NCoR1 mediates papillomavirus E8;E2C transcriptional repression. J. Virol. 2010 May;84(9):4451-60
    Powell ML et al
    2010/01/01
  • 備考:
    Application: WB
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Rahman S et al. The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3. Mol. Cell. Biol. 2011 Jul;31(13):2641-52
    Rahman S et al
    2011/01/01
  • 備考:
    Application: ChIP
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Mertz JA et al. Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc. Natl. Acad. Sci. U.S.A. 2011 Oct;108(40):16669-74
    Mertz JA et al
    2011/01/01
  • 備考:
    Application: ChIP
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Zhu J et al. Reactivation of latent HIV-1 by inhibition of BRD4. Cell Rep 2012 Oct;2(4):807-16
    Zhu J et al
    2012/01/01
  • 備考:
    Application: WB
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Zou Z et al. Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA. Oncogene 2013 May;
    Zou Z et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Domsic JF et al. Molecular basis for oligomeric-DNA binding and episome maintenance by KSHV LANA. PLoS Pathog. 2013;9(10):e1003672
    Domsic JF et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Wu X et al. Bromodomain and extraterminal (BET) protein inhibition suppresses human T cell leukemia virus 1 (HTLV-1) Tax protein-mediated tumorigenesis by inhibiting nuclear factor κB (NF-κB) signaling. J. Biol. Chem. 2013 Dec;288(50):36094-10
    Wu X et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Anders L et al. Genome-wide localization of small molecules. Nat. Biotechnol. 2014 Jan;32(1):92-6
    Anders L et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Patel AJ et al. BET bromodomain inhibition triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors through Bim induction. Cell Rep 2014 Jan;6(1):81-92
    Patel AJ et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    McLure KG et al. RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist. PLoS ONE 2013;8(12):e83190
    McLure KG et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Meng S et al. BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction. J. Dent. Res. 2014 May;93(7):657-662
    Meng S et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Sahai V et al. BET Bromodomain Inhibitors Block Growth of Pancreatic Cancer Cells in Three-Dimensional Collagen. Mol. Cancer Ther. 2014 May;
    Sahai V et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Michaeloudes C et al. Bromodomain and extraterminal proteins suppress NF-E2-related factor 2-mediated antioxidant gene expression. J. Immunol. 2014 May;192(10):4913-20
    Michaeloudes C et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Feng Q et al. An epigenomic approach to therapy for tamoxifen-resistant breast cancer. Cell Res. 2014 Jul;24(7):809-19
    Feng Q et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    French CA et al. NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism. Cancer Discov 2014 Aug;4(8):928-41
    French CA et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Long J et al. The BET Bromodomain Inhibitor I-BET151 Acts Downstream of Smoothened Protein to Abrogate the Growth of Hedgehog Protein-driven Cancers. J. Biol. Chem. 2014 Dec;289(51):35494-502
    Long J et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Horne GA et al. Nanog requires BRD4 to maintain murine embryonic stem cell pluripotency and is suppressed by bromodomain inhibitor JQ1 together with Lefty1. Stem Cells Dev. 2015 Apr;24(7):879-91
    Horne GA et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Park-Min KH et al. Inhibition of osteoclastogenesis and inflammatory bone resorption by targeting BET proteins and epigenetic regulation. Nat Commun 2014;5:5418
    Park-Min KH et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed